Viking Therapeutics, Inc.

NASDAQ:VKTX

27.55 (USD) • At close May 9, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q4
Revenue 000000.43600000000000000000000000000000000000000000000
Cost of Revenue 000.0870.0750.0740.0740.0730.0730.0720.0720.14200.0770.0760.0750.0730.072000000000000000000000000000000000
Gross Profit 00-0.087-0.075-0.0740.362-0.073-0.073-0.072-0.072-0.1420-0.077-0.076-0.075-0.073-0.072000000000000000000000000000000000
Gross Profit Ratio 000000.8300000000000000000000000000000000000000000000
Reseach & Development Expenses 41.39130.98722.78523.76924.10320.50218.37913.91711.00816.17811.95913.54212.5559.84710.79512.80411.5359.0487.1167.787.9876.4515.2797.3334.4965.0895.6875.2213.0433.0333.4653.7153.5282.6472.1052.3711.8773.2192.5081.1010.1390.1430.78921.2420.050.0040.0040.0030.0010.069
General & Administrative Expenses 14.07815.25113.77110.2859.978.7838.8869.8239.5294.1054.2374.0893.692.6632.6082.7372.6932.2172.7272.8262.9612.4222.162.2362.311.9481.7071.7041.7621.3941.2271.2671.4411.091.1591.2071.391.4011.7811.5260.3220.2110.360.5140.160.0330.0330.0140.0030.041
Selling & Marketing Expenses 000-0.075000000000000000000000000000000000000000000.0040.004000
SG&A 14.07815.25113.77110.219.978.7838.8869.8239.5294.1054.2374.0893.692.6632.6082.7372.6932.2172.7272.8262.9612.4222.162.2362.311.9481.7071.7041.7621.3941.2271.2671.4411.091.1591.2071.391.4011.7811.5260.3220.2110.360.5140.160.0370.0370.0140.0030.041
Other Expenses 0000000000000000000000000-1.39800.0371.3610.633-1.1360.5710.2780.62-0.0650.4120.097-0.217-0.197-4.968-5.0432.0711.109-0.957-0.01000-00
Operating Expenses 55.46946.23836.55633.97934.07329.28527.26523.7420.53720.28316.19617.63116.24512.5113.40315.54114.22811.2659.84310.60610.9488.8737.4399.5696.8067.0377.3946.9254.8054.4274.6924.9834.9693.7383.2643.5783.2674.624.2882.6270.4610.3541.14921.7560.210.0510.0510.0170.0030.11
Operating Income -55.469-46.238-36.556-34.054-34.073-29.285-27.265-23.74-20.537-20.283-16.196-17.631-16.245-12.51-13.403-15.541-14.228-11.265-9.843-10.606-10.948-8.873-7.439-9.569-6.806-7.037-7.394-6.925-4.805-4.427-4.692-4.983-4.969-3.738-3.264-3.578-3.267-4.62-4.288-2.627-0.461-0.354-1.149-21.756-0.21-0.04-0.04-0.017-0.003-0.11
Operating Income Ratio 00000-67.16700000000000000000000000000000000000000000000
Total Other Income Expenses Net 9.8410.82111.61611.8046.7174.684.7314.5151.0060.7240.4230.1990.1420.1540.160.160.2180.3170.5551.0341.2611.4231.7081.8951.8821.7970.7940.2531.2540.343-1.408-0.189-0.2530.093-0.543-0.115-0.32-0.471-0.448-5.238-5.251.7430.887-1.027-0.019-0.019-0.019-0.005-0.001-0.001
Income Before Tax -45.629-35.417-24.94-22.25-27.356-24.605-22.534-19.225-19.531-19.559-15.773-17.432-16.103-12.356-13.243-15.381-14.01-10.948-9.288-9.572-9.687-7.45-5.731-7.674-4.924-5.24-6.6-6.672-3.551-4.084-6.1-5.172-5.222-3.645-3.807-3.693-3.587-5.091-4.737-7.865-5.7111.389-0.262-22.783-0.229-0.06-0.06-0.022-0.005-0.111
Income Before Tax Ratio 00000-56.43300000000000000000000000000000000000000000000
Income Tax Expense 00000.0311.152-0.073-0.073-1.006-0.724-0.423-0.241-0.142-0.2300.1810-0.388-0.555-1.034-1.2611.377-1.7021.854-1.884-1.8090-0.2160.1070.290.2720.760.5310.5270.4790.5270.4160.2540.2510.270.2070.3280.2220.070.009-0.019-0.019-0.0170.0010
Net Income -45.629-35.417-24.94-22.25-27.356-24.605-22.534-19.225-18.525-18.835-15.35-17.432-15.961-12.356-13.243-15.381-14.01-10.948-9.288-9.572-9.687-7.45-5.731-7.674-4.924-5.24-6.6-6.672-3.551-4.084-6.1-5.172-5.222-3.645-3.807-3.693-3.587-5.091-4.737-7.865-5.7111.389-0.262-22.783-0.229-0.06-0.06-0.022-0.005-0.111
Net Income Ratio 00000-56.43300000000000000000000000000000000000000000000
EPS -0.41-0.32-0.22-0.2-0.26-0.25-0.23-0.19-0.24-0.25-0.2-0.23-0.21-0.16-0.17-0.2-0.19-0.15-0.13-0.13-0.13-0.1-0.08-0.11-0.069-0.074-0.11-0.13-0.08-0.14-0.22-0.21-0.23-0.18-0.2-0.22-0.4-0.56-0.53-1.07-0.620.32-0.061-5.29-0.053-0.024-0.024-0.003-0.001-0.026
EPS Diluted -0.41-0.32-0.22-0.2-0.26-0.25-0.23-0.19-0.24-0.25-0.2-0.23-0.21-0.16-0.17-0.2-0.19-0.15-0.13-0.13-0.13-0.1-0.08-0.11-0.069-0.074-0.11-0.13-0.078-0.14-0.22-0.21-0.23-0.18-0.2-0.22-0.4-0.56-0.53-1.07-0.620.32-0.061-5.29-0.053-0.024-0.024-0.003-0.001-0.026
EBITDA -55.469-46.128-36.556-34.054-33.999-29.211-27.265-23.74-20.465-20.211-16.196-17.631-16.168-12.434-13.328-15.468-14.228-11.265-9.843-9.484-10.948-7.404-7.439-7.674-4.922-5.21-6.6-6.526-3.239-3.769-4.692-4.983-4.969-3.21-3.264-3.166-3.267-4.62-4.288-7.595-5.5041.717-0.04-22.713-0.2200-0.005-0.003-0.11
EBITDA Ratio 00000-66.99800000000000000000000000000000000000000000000